STOCK TITAN

Gh Research Plc Financials

GHRS
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Gh Research Plc (GHRS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral
4/9

Gh Research Plc passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality
0.90x

For every $1 of reported earnings, Gh Research Plc generates $0.90 in operating cash flow (-$43.6M OCF vs -$48.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
-$48.3M
YoY-23.9%

Gh Research Plc reported -$48.3M in net income in fiscal year 2025. This represents a decrease of 23.9% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
-$43.7M
YoY-3.2%

Gh Research Plc generated -$43.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 3.2% from the prior year.

Cash & Debt
$246.3M
YoY+144.3%
5Y CAGR+110.9%

Gh Research Plc held $246.3M in cash against $147K in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
62M
YoY+19.2%

Gh Research Plc had 62M shares outstanding in fiscal year 2025. This represents an increase of 19.2% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
-17.3%
YoY+4.5pp
5Y CAGR-9.4pp

Gh Research Plc's ROE was -17.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.5 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$121K
YoY+146.9%

Gh Research Plc invested $121K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 146.9% from the prior year.

GHRS Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A $0 $0 $0 N/A $0 $0 $0
Net Income N/A -$14.0M-50.9% -$9.3M+14.1% -$10.8M N/A -$12.1M-16.7% -$10.4M-35.4% -$7.7M
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

GHRS Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $288.2M-4.6% $302.0M-3.6% $313.4M-2.2% $320.5M+70.2% $188.3M-5.7% $199.6M-3.6% $207.0M-4.9% $217.6M
Current Assets $286.0M-3.0% $294.8M+0.3% $293.9M-0.3% $294.7M+91.1% $154.2M-0.5% $154.9M+1.3% $152.9M-4.7% $160.5M
Cash & Equivalents $246.3M-1.4% $249.7M-1.7% $253.9M+3.6% $245.0M+143.0% $100.8M+11.9% $90.1M+3.4% $87.1M+12.5% $77.5M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $8.5M-19.7% $10.6M+3.7% $10.2M+0.1% $10.2M+9.8% $9.3M-9.0% $10.2M+23.4% $8.3M+5.9% $7.8M
Current Liabilities $8.4M-19.5% $10.4M+4.4% $10.0M+0.5% $9.9M+10.8% $9.0M-8.5% $9.8M+25.4% $7.8M+7.2% $7.3M
Long-Term Debt $147K-32.3% $217K-23.3% $283K-12.1% $322K-12.7% $369K-19.4% $458K-7.8% $497K-11.4% $561K
Total Equity $279.7M-4.0% $291.4M-3.9% $303.2M-2.3% $310.2M+73.4% $179.0M-5.5% $189.4M-4.7% $198.7M-5.3% $209.7M
Retained Earnings -$154.4M-10.1% -$140.3M-11.1% -$126.3M-7.9% -$117.0M-10.0% -$106.4M-9.0% -$97.6M-14.1% -$85.6M-13.3% -$75.5M

GHRS Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow -$12.3M+9.9% -$13.7M-52.6% -$9.0M-4.6% -$8.6M+17.9% -$10.4M+15.1% -$12.3M-23.9% -$9.9M-3.5% -$9.6M
Capital Expenditures $19K-51.3% $39K-33.9% $59K+1375.0% $4K-84.0% $25K+525.0% $4K-50.0% $8K-33.3% $12K
Free Cash Flow -$12.3M+10.0% -$13.7M-52.0% -$9.0M-5.2% -$8.6M+18.1% -$10.5M+14.9% -$12.3M-23.8% -$9.9M-3.5% -$9.6M
Investing Cash Flow $8.8M-9.6% $9.8M-37.7% $15.7M+32.7% $11.8M-44.5% $21.3M+39.6% $15.3M-22.5% $19.7M+124.5% $8.8M
Financing Cash Flow -$68K-3.0% -$66K+93.8% -$1.1M-100.8% $140.9M+238842.4% -$59K+1.7% -$60K+47.4% -$114K-60.6% -$71K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

GHRS Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A -4.8%-1.7pp -3.1%+0.4pp -3.5% N/A -6.4%-1.2pp -5.2%-1.6pp -3.6%
Return on Assets N/A -4.6%-1.7pp -3.0%+0.4pp -3.4% N/A -6.1%-1.1pp -5.0%-1.5pp -3.5%
Current Ratio 34.13+5.8 28.32-1.2 29.49-0.2 29.71+12.5 17.23+1.4 15.83-3.8 19.60-2.5 22.06
Debt-to-Equity 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.00
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

No, Gh Research Plc (GHRS) reported a net income of -$48.3M in fiscal year 2025.

As of fiscal year 2025, Gh Research Plc (GHRS) had $246.3M in cash and equivalents against $147K in long-term debt.

Gh Research Plc (GHRS) has a return on equity of -17.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Gh Research Plc (GHRS) generated -$43.7M in free cash flow during fiscal year 2025. This represents a -3.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Gh Research Plc (GHRS) generated -$43.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Gh Research Plc (GHRS) had $288.2M in total assets as of fiscal year 2025, including both current and long-term assets.

Gh Research Plc (GHRS) invested $121K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Gh Research Plc (GHRS) had 62M shares outstanding as of fiscal year 2025.

Gh Research Plc (GHRS) had a current ratio of 34.13 as of fiscal year 2025, which is generally considered healthy.

Gh Research Plc (GHRS) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Gh Research Plc (GHRS) had a return on assets of -16.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Gh Research Plc (GHRS) had $246.3M in cash against an annual operating cash burn of $43.6M. This gives an estimated cash runway of approximately 68 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Gh Research Plc (GHRS) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Gh Research Plc (GHRS) has an earnings quality ratio of 0.90x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top